| 1989 |
PTN (designated HBGF-8) was purified to near homogeneity from bovine uterus as a novel 17 kDa heparin-binding growth factor with mitogenic activity on NIH 3T3 fibroblasts, stimulating DNA synthesis at potency comparable to aFGF; its unique N-terminal amino acid sequence distinguished it from bFGF. |
Protein purification (heparin-Sepharose affinity chromatography, cation exchange), N-terminal amino acid sequencing, 3H-thymidine incorporation mitogenic assay |
Biochemical and biophysical research communications |
High |
2610682
|
| 1991 |
PTN (HBNF) was purified to homogeneity from bovine brain and structurally characterized as a 136-amino acid protein (~15.5 kDa calculated, ~18 kDa apparent), with C-terminally truncated isoforms identified when protease inhibitors were omitted during extraction, indicating susceptibility to proteolytic processing at the C-terminus. |
Protein purification (pH 4.5 extraction, ammonium sulfate precipitation, cation exchange, heparin-Sepharose, reverse phase HPLC), amino acid sequencing, SDS-PAGE, amino acid composition analysis |
Growth factors (Chur, Switzerland) |
High |
2049182
|
| 1990 |
PTN (HBNF) and midkine (MK) were identified as members of a novel family of homologous heparin-binding proteins with ~55% structural homology and complete alignment of 9 cysteine residues, suggesting similar 3D structures; PTN stimulates neurite outgrowth in neurons. |
cDNA cloning, nucleotide sequencing, amino acid sequence comparison, structural alignment |
Biochemical and biophysical research communications |
High |
1700712
|
| 1999 |
PTN (HARP) forms noncovalent dimers, and dimerization is promoted by heparin and other sulfated glycosaminoglycans (dermatan sulfate, chondroitin sulfate-C); chlorate treatment of cells (which inhibits sulfation) prevents dimerization, and PTN is secreted as a dimer in conditioned medium of NIH-3T3 cells overexpressing the protein. |
DSS cross-linking, affinity chromatography, chlorate treatment of cells, conditioned medium analysis |
Biochemical and biophysical research communications |
Medium |
10600521
|
| 2000 |
A human endogenous retrovirus-like element (HERV-E.PTN) inserted into the PTN gene generates a novel promoter driving HERV-PTN fusion transcripts in choriocarcinoma and trophoblastic tissue; a retroviral Sp1-binding site within an enhancer region (+443 to +486) is essential for PTN expression in choriocarcinoma cells, as shown by site-specific mutation abolishing activity. |
In situ hybridization, transient transfection reporter assays, deletion analysis, EMSA, supershift assays, chromatin immunoprecipitation, Sp1 overexpression in Drosophila SL2 cells, site-directed mutagenesis |
Oncogene |
High |
10962555
|
| 2009 |
IFN-γ markedly induces PTN mRNA expression in macrophages via the JAK/STAT1 signaling pathway; STAT1 (but not STAT3 or p42) binds a gamma-activated sequence (GAS) at -2086 to -2078 bp in the PTN promoter at the chromatin level, and siRNA knockdown of STAT1 markedly reduces PTN mRNA levels. |
Janus kinase inhibitors, STAT1 siRNA knockdown, STAT1/STAT3/p42 phosphorylation analysis, PTN promoter analysis, EMSA, supershift assays, chromatin immunoprecipitation |
FASEB journal |
High |
19917672
|
| 2010 |
Menin represses PTN transcription, and PTN signals through its receptor RPTP β/ζ together with integrin αvβ3, FAK, PI3K, and phospho-ERK1/2 to regulate lung cancer cell migration; ectopic menin expression reduces RPTP β/ζ expression indirectly through repression of PTN. |
Ectopic menin overexpression, PTN transcription repression assays, cell migration assays (A549 cells), pathway inhibitor studies (PI3K, FAK), signaling protein analysis |
Oncogene |
Medium |
20639902
|
| 2013 |
PTN activates ALK through a 'ligand independent' mechanism: PTN binds and inactivates the phosphatase activity of RPTP β/ζ, which normally dephosphorylates phosphotyrosine sites in the ALK activation domain; inactivation of RPTP β/ζ by PTN leads to ALK autophosphorylation and autoactivation. |
Review synthesizing biochemical pathway studies; mechanism established by referenced primary experiments on PTN/RPTPβ/ζ/ALK signaling |
Biochimica et biophysica acta |
Medium |
23777859
|
| 2014 |
PTN signals through its receptor PTPRZ1 in epithelial ovarian cancer cells; siRNA-mediated knockdown of PTN or PTPRZ1 induces apoptosis, and expression profiling after PTN silencing identifies MAPK family members as likely effectors of PTN survival signaling in EOC cells. |
siRNA knockdown of PTN and PTPRZ1, apoptosis assays, 36-gene expression profiling, computational pathway mapping |
Molecular carcinogenesis |
Medium |
25418856
|
| 2019 |
PTN signals through PTPRZ to promote oligodendrocyte precursor cell (OPC) differentiation via the PI3K-AKT pathway; PTPRZ dephosphorylates AFAP1L2 at tyrosine residues in vitro and in HEK293T cells, and PTN treatment enhances phosphorylation of AFAP1L2, AKT, and mTOR; knockdown of AFAP1L2 or PI3K inhibition suppresses OPC differentiation; knock-in mice with catalytically inactive PTPRZ (Cys→Ser) show accelerated OPC differentiation and earlier remyelination after cuprizone-induced demyelination. |
In vitro phosphatase assay, HEK293T cell transfection, OL1 cell knockdown, PI3K inhibitor, PTPRZ catalytic dead knock-in mouse, cuprizone demyelination model, western blot, immunostaining |
Glia |
High |
30667096
|
| 2018 |
Adult hippocampal neural stem cells (NSCs) continuously supply PTN as a feedforward signal to newborn neurons; conditional ablation of PTN in NSCs causes defective dendritic development and arborization of newborn neurons, establishing NSC-derived PTN as a niche factor governing newborn neuron maturation. |
Cell ablation, retrovirus-mediated single-cell labeling, signaling pathway modulation, conditional PTN deletion in NSCs, morphological analysis of dendritic arborization |
Neuron |
High |
30497772
|
| 2005 |
JUN (AP-1 subunit) in dermal fibroblasts transcriptionally regulates PTN expression; PTN exerts a mitogenic effect on primary human keratinocytes in a heterologous feeder layer co-culture system; co-cultivation with keratinocytes stimulates PTN expression in fibroblasts, and PTN is upregulated during cutaneous wound healing in vivo. |
Gene expression profiling of wild-type vs. Jun-/- mouse embryonic fibroblasts, semi-quantitative RT-PCR, in situ hybridization on murine skin sections, heterologous co-culture system, in vivo wound healing model |
Journal of cell science |
Medium |
15840658
|
| 2012 |
In mammary epithelial cells, endogenous PTN signals through ALK to regulate cell motility, invasion, and progenitor maintenance; blocking endogenous PTN with a monoclonal antibody increases mammosphere formation with laminin deposition and upregulates progenitor markers; in vivo, PTN inhibits ductal outgrowth and branching via inhibition of phospho-ERK1/2 signaling in mammary epithelial cells. |
Anti-PTN blocking antibody treatment, real-time impedance monitoring, 3D culture mammosphere assay, immunostaining, in vivo mammary gland development analysis, ERK1/2 phosphorylation assay |
PloS one |
Medium |
23077670
|
| 1992 |
Recombinant PTN (HBNF) inhibits infectivity of herpes simplex virus types 1 and 2 and human cytomegalovirus; carboxymethylated HBNF, which retains heparin-Sepharose affinity, loses antiviral activity, indicating that the antiviral mechanism depends on competition for specific binding to cell surface heparan sulfate proteoglycans. |
Viral infectivity assays, chemical modification (carboxymethylation) of HBNF, heparin-Sepharose binding assay |
Biochemical and biophysical research communications |
Medium |
1335242
|
| 2018 |
Chemotherapy drives upregulation of PTN and its receptor PTPRZ1 in triple-negative breast cancer cells via CDKN1A; the CDKN1A/PTN/PTPRZ1 axis promotes chemoresistance by activating the NF-κB pathway, increasing tumor proliferation and inhibiting apoptosis; siRNA knockdown confirmed PTPRZ1 as the downstream effector. |
Microarray analysis, siRNA knockdown, CCK-8 proliferation assay, colony formation assay, apoptosis analysis, NF-κB pathway analysis |
Cell communication and signaling |
Medium |
30497491
|
| 2011 |
Adenoviral shRNA-mediated knockdown of PTN in pancreatic cancer BxPC-3 cells reduces PTN mRNA and protein, and co-culture of dorsal root ganglion (DRG) neurons with PTN-depleted BxPC-3 cells results in significant reduction in neurite number and length, demonstrating that tumor cell-derived PTN promotes DRG neurite outgrowth. |
Adenoviral shRNA knockdown, RT-PCR, immunocytochemistry, Western blotting, DRG co-culture neurite outgrowth assay |
World journal of gastroenterology |
Medium |
21677838
|
| 2024 |
PTN from Leydig cells binds to its receptor syndecan-2 (SDC2) on spermatogonial stem cells (SSCs); SDC2 knockdown impairs SSC proliferation, DNA synthesis, and PLZF expression, and downregulates GFRA1 and the HIF-1 signaling pathway; exogenous PTN rescues proliferation and GFRA1 expression in SDC2 knockdown SSC lines, establishing the PTN-SDC2-GFRA1 axis in human SSC regulation. |
Single-cell sequencing analysis, immunofluorescence, STRING prediction, co-immunoprecipitation, SDC2 knockdown, transcriptome analysis, exogenous PTN rescue experiments |
Biological research |
Medium |
39285301
|
| 2025 |
PTN secreted by cardiac fibroblasts acts on syndecan-4 (SDC4) receptor to promote cardiac fibroblast proliferation/invasion and stimulate macrophage inflammatory responses (TNF-α, IL-6, Cox-2) in pressure overload-induced hypertrophic cardiomyopathy; the PTN-SDC4 pathway was validated both in vitro and in vivo using TAC mouse model. |
scRNA-seq, CellChat cell-cell interaction analysis, WGCNA, RT-qPCR, EdU staining, transwell assay, western blot, immunofluorescence, TAC mouse model, echocardiography |
Life sciences |
Medium |
39765325
|
| 2025 |
PTN directly binds SIRT1 and activates AMPK phosphorylation at Thr172, triggering the AMPK-PGC1α axis to reprogram mitochondrial energy metabolism; PTN overexpression reduces oxidative stress and apoptosis in cardiomyocytes and improves cardiac function in a doxorubicin cardiotoxicity model. |
PTN overexpression in cellular and animal DIC models, western blot, AMPK phosphorylation assay, mitochondrial function assays, PTN-SIRT1 binding assay, in vivo cardiac function assessment |
Acta biochimica et biophysica Sinica |
Medium |
41640280
|
| 2025 |
PTN binds PTPRZ1 receptor and induces PLCG1 phosphorylation and NCOA3 nuclear translocation to regulate antioxidant functions and reduce ROS in rat bone marrow mesenchymal stem cells, promoting osteogenic differentiation; PTN inhibited apoptosis and enhanced osteogenesis in vitro, and promoted fracture healing in osteoporotic rats in vivo. |
RT-qPCR, immunofluorescence, ALP detection, TUNEL assay, RNA sequencing, phosphorylation quantitative proteomics, fracture healing in osteoporosis rat model |
Biomedicines |
Medium |
40149671
|
| 2024 |
Astrocyte-derived PTN promotes hippocampal neurogenesis by cooperating with PTPRZ1 or ALK receptors to activate the AKT signaling pathway; conditional ablation of PTN in astrocytes exacerbates neurogenic deficits in demyelinated hippocampus, while astrocyte-specific PTN overexpression reverses neurogenic and cognitive impairments caused by demyelination. |
Conditional genetic deletion of PTN in astrocytes, PTN overexpression in astrocytes, demyelination (cuprizone) model, AKT signaling pathway analysis, hippocampal neurogenesis quantification, cognitive behavioral tests |
Stem cell reports |
Medium |
39729991
|
| 2025 |
In the prostate, androgen receptor (AR) signaling controls epithelial homeostasis partly through a stromal signal mediated by secreted PTN; castration-induced ferroptosis in prostate epithelium is regulated by PTN as an extrinsic stromal pathway (alongside an intrinsic NKX3.1-dependent pathway), with PTN signaling coordinating monounsaturated fatty acid phospholipid biosynthesis and GPX4 expression to suppress ferroptosis. |
Genetically engineered mouse models, human organotypic cultures, castration experiments, in vivo analysis of AR signaling pathways, lipid and GPX4 expression analysis |
bioRxivpreprint |
Medium |
bio_10.1101_2025.08.06.668974
|
| 2024 |
PTN secretion from oligodendrocyte precursor cells (OPCs) is regulated by TRAPPC12 and Mea6/cTAGE5 via COPII-dependent ER exit; Mea6/cTAGE5 ablation in OPCs disrupts PTN secretion, and exogenous PTN supplementation ameliorates OPC differentiation deficits, demonstrating PTN acts as a secreted factor downstream of the Mea6/TRAPPC12 trafficking machinery to support white matter development. |
Conditional knockout of Mea6/cTAGE5 in OPCs, TRAPPC12 knockdown in CG4/OPC cells, co-immunoprecipitation (TRAPPC12-Mea6 interaction), PTN secretion measurement, exogenous PTN rescue experiment, OPC differentiation assays, behavioral phenotyping |
iScience |
Medium |
38439956
|
| 2025 |
PTN released by dysregulated quiescent neural stem cells (qNSCs) is a key factor contributing to manic-like phenotypes in Shank3-overexpressing mice; pharmacological and molecular inhibition of PTN in qNSCs rescued aberrant neurogenesis and alleviated manic-like social deficits, placing PTN downstream of Shank3 overexpression in qNSCs. |
scRNA-seq analysis, conditional Shank3 overexpression mouse model, pharmacological PTN inhibition, molecular (genetic) PTN inhibition in qNSCs, neurogenesis quantification, behavioral assays |
Nature communications |
Medium |
40069581
|
| 2014 |
CART neuropeptide facilitates neurite outgrowth in cortical neurons after oxygen-glucose deprivation (OGD) through a PTN-dependent pathway; siRNA-mediated PTN knockdown abolishes CART-stimulated increases in GAP43 protein levels, placing PTN as a required downstream mediator of CART neuroprotective signaling. |
Primary cortical neuron OGD model, siRNA knockdown of PTN, western blot for GAP43, flow cytometry for apoptosis |
Neuroscience |
Low |
25010400
|